Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial-Reference-Cited by-同舟云学术

Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial

Published:2022-08-28 Issue:9 Volume:28 Page:1823-1830
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Rizas Konstantinos D.^ORCID,Freyer Luisa,Sappler Nikolay,von Stülpnagel Lukas^ORCID,Spielbichler Peter,Krasniqi Aresa,Schreinlechner Michael,Wenner Felix N.,Theurl Fabian^ORCID,Behroz Amira,Eiffener Elodie^ORCID,Klemm Mathias P.,Schneidewind Annika,Zens Martin,Dolejsi Theresa,Mansmann Ulrich^ORCID,Massberg Steffen^ORCID,Bauer Axel^ORCID

Funder

Ludwig-Maximilians-University Munich, Germany Pfizer Pharma GmbH, Germany

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-022-01979-w.pdf

Reference32 articles.

1. Kornej, J., Benjamin, E. J. & Magnani, J.W. Atrial fibrillation: global burdens and global opportunities. Heart https://doi.org/10.1136/heartjnl-2020-318480 (2021).

2. Krijthe, B. P. et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur. Heart J. 34, 2746–2751 (2013).

3. Hindricks, G. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 42, 373–498 (2021).